Page 22 - David Lim News Today

The House is slated to consider legislation later this week funding the FDA and the Department of Agriculture for fiscal 2024.

Scientists are heralding Eisai’s Leqembi and Lilly’s donanemab as the dawn of “the decade of Alzheimer’s.”

The bills include legislation that would permanently allow telehealth to be a standalone benefit, a sweeping pandemic preparedness package and the reauthorization of the SUPPORT Act.

Some public health experts worry the FDA has set impossible standards for menthol vapes.

The San Mateo-Foster City School District has named a new principal to lead Abbott Middle School, yet, some parents — while happy that leadership has been formalized — want to

The FDA made history Thursday by approving Opill, a drug from the generic pharmaceutical manufacturer Perrigo.

From Alzheimer’s advocacy groups to the chair of the Senate’s most powerful health care committee to independent drug value estimators, serious questions are being raised about how much and how many Alzheimer’s patients will be helped by Leqembi.

Earlier this year, the FDA granted the Alzheimer's drug, made by Eisai and Biogen, accelerated approval based on preliminary data.

A federal judge ruled that the Biden administration’s efforts to influence social media posts about Covid-19 likely violated the first amendment.

Health care facilities seeking state approval of significant changes now have to file independent reports on how their project would affect health outcomes and access to care among medically underserved groups.